ceres inc (CERE:NASDAQ GM)

Executive Profile*

Background*

Mr. Edmund Martin Olivier de Vezin, Ned, is the Senior General Partner at Oxford Bioscience Partners. He founded the firm in 1993 and also serves as its General Partner. Mr. Olivier De Vezin is a Partner of Coastview Capital, LLC. He serves as Managing Director of Europe of Sasol North America, Inc. From 1983 to 1993, he served as a General Partner and Principal of Fairfield/Steuben Venture Partners investing in life science companies. At Diamond Shamrock, he served ... as a Vice President of Technology and Planning in charge of corporate research, engineering, venture capital, planning, and mergers and acquisitions. He served as a Managing Director of Convergent Venture Partners, L.P. From 1972 to 1980, Mr. Olivier De Vezin served as a Corporate Vice President and General Manager of the Worldwide Scientific Products Division and Vice President of Commercial Development at Corning Incorporated, where he initiated Corning's entry into industrial biotechnology. From 1965 to 1972, Mr. Olivier De Vezin held a variety of positions at Conoco Chemical Company, including as its Managing Director of Europe. He served as a Principal of Biobank Technology Ventures LLC and Biobank, a Life Science Community. Prior to venture capital with Fairfield/Steuben Venture Partners, Mr. Olivier De Vezin managed domestic and international operations for Diamond Shamrock, Corning Glass Works, and Conoco Chemicals. He served as the Chairman of Biotechnology Venture Investors Group. He served as a Vice Chairman of the Supervisory Board of Exonhit Therapeutics SA until April 2008. He served as a Non-Executive Vice Chairman of Oxford BioScience Partners. Mr. Olivier De Vezin has been a Director of Trans-India Acquisition Corp., since July 2006. He Co-founded Ceres Inc., and has been its Director since March 1996. He serves as Director of Egeen International Corporation and Serono Genetics Institute SA. He serves as a Member of Advisory Board and Director of Oxford Bioscience Partners. Mr. Olivier De Vezin serves as a Director of the South Coast Repertory Theatre and a Life Fellow and a Member of the National Council of the Salk Institute. He served as a Director of Sosei Co. Ltd., an Oxford portfolio company. He served as a Director of Astex Therapeutics Limited. He served as Member of supervisory board of Exonhit Therapeutics SA until April 2008. He served as a Trustee of the Union Theological Seminary. He received an M.B.A. from Harvard Graduate School of Business (Baker Scholar, High Distinction) and a B.S. in Chemical Engineering from Rice University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
CERE:US	$2.21 USD	+0.01

COMPETITOR COMPENSATION